Cargando…
BODIPYs in PDT: A Journey through the Most Interesting Molecules Produced in the Last 10 Years
Over the past 30 years, photodynamic therapy (PDT) has shown great development. In the clinical setting the few approved molecules belong almost exclusively to the porphyrin family; but in the scientific field, in recent years many researchers have been interested in other families of photosensitize...
Autores principales: | Malacarne, Miryam Chiara, Gariboldi, Marzia Bruna, Caruso, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456687/ https://www.ncbi.nlm.nih.gov/pubmed/36077597 http://dx.doi.org/10.3390/ijms231710198 |
Ejemplares similares
-
Free and Poly-Methyl-Methacrylate-Bounded BODIPYs: Photodynamic and Antimigratory Effects in 2D and 3D Cancer Models
por: Ballestri, Marco, et al.
Publicado: (2022) -
Preliminary Toxicity Evaluation of a Porphyrin Photosensitizer in an Alternative Preclinical Model
por: Malacarne, Miryam Chiara, et al.
Publicado: (2023) -
Combination of PDT and NOPDT with a Tailored BODIPY Derivative
por: Lazzarato, Loretta, et al.
Publicado: (2019) -
NI-BODIPY-GO Nanocomposites
for Targeted PDT
por: Öztürk Gündüz, Ezel, et al.
Publicado: (2023) -
Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights
por: Marras, Emanuela, et al.
Publicado: (2023)